Collegium Pharmaceutical, Inc. (COLL)
NASDAQ · Manufacturing · Pharmaceutical preparations
$22.53−$0.1100 (−0.49%) on the dayAs of the close; data may be delayed.
COLL price, last 12 months
Key stats
- Previous close
- $22.64
- Open
- $22.58
- Day range
- $22.29 – $22.91
- 52-week range
- $21.65 – $50.79
- Volume
- 503.4K
- Avg volume (20 days)
- 950.7K
- Market cap
- $733.5M
Performance
1W−1.1%
1M−18.1%
3M−38.4%
6M−32.6%
YTD−51.3%
1Y−35.9%
vs S&P 500, 1Y−52.7 pts
Technicals and fundamentals
About Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $733.5M